InsiderDB

Lobbying disclosures · Lobbying report

LLY: third_quarter 2026 lobbying report

International and domestic tax issues. Implementation of PL 119-21. 340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267). Issues related to drug pricing; Issues related to reimbursement of insulin products and obesity medications: Issues related to most favored nation pricing polices. Accelerated approval pathway; support for Alzheimer's diagnostics;

Follow LLY
Became public
Oct 20, 2026, 4:47 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 7:37 PM EST

Why this is connected

Legal-name match: ELI LILLY & COMPANY is ELI LILLY & Co (https://www.sec.gov/Archives/edgar/data/59478/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a1045060-72de-45fa-9151-42967b56af1d/","filing_uuid":"a1045060-72de-45fa-9151-42967b56af1d","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a1045060-72de-45fa-9151-42967b56af1d/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-10-20T16:47:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":151533,"url":"https://lda.gov/api/v1/clients/151533/","client_id":1006435,"name":"ELI LILLY & COMPANY","general_description":"Pharmaceutical/ Health Products","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-04-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"International and domestic tax issues. Implementation of PL 119-21.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":43332,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"W","last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69840,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":"E.","last_name":"WILCOX","suffix":null,"suffix_display":null},"covered_position":"LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing; Issues related to reimbursement of insulin products and obesity medications: Issues related to most favored nation pricing polices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":43332,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"W","last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69840,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":"E.","last_name":"WILCOX","suffix":null,"suffix_display":null},"covered_position":"LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings","new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor Issues related to intellectual property protection and market access within current trade negotiations. Section 232 investigations and other tariff issues. Pharmaceutical IP issues, march-in rights. Issues related to China WRT the BINSA bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69840,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":"E.","last_name":"WILCOX","suffix":null,"suffix_display":null},"covered_position":"LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings","new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to pharmaceutical manufacturing and development. Issues related to China WRT the BINSA bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69840,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":"E.","last_name":"WILCOX","suffix":null,"suffix_display":null},"covered_position":"LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings","new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug importation, prescription drug safety, value and access.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in LLY

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.